ID
18592
Description
A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT Concomitant Medications
Keywords
Versions (2)
- 11/2/16 11/2/16 -
- 11/11/16 11/11/16 -
Uploaded on
November 11, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant Medications Galafold (migalastat) AT1001-012 NCT01218659
Concomitant Medications Galafold (migalastat) AT1001-012 NCT01218659
Description
Prior/Concomitant Medications
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C0013227
Description
concomitant medications
Data type
integer
Alias
- UMLS CUI [1]
- C2347852
- UMLS CUI [2]
- C0013227
Description
If there are any prior/concomitant medications to report, please specify
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Description
If there are any prior/concomitant medications to report, please specify
Data type
text
Alias
- UMLS CUI [1]
- C3146298
Description
If there are any prior/concomitant medications to report, please specify
Data type
date
Alias
- UMLS CUI [1]
- C0808070
Description
If there are any prior/concomitant medications to report, please specify
Data type
date
Alias
- UMLS CUI [1]
- C0806020
Description
type of application of medication
Alias
- UMLS CUI-1
- C3469597
- UMLS CUI-2
- C0013227
Description
If there are any prior/concomitant medications to report, please specify
Data type
integer
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0013227
Similar models
Concomitant Medications Galafold (migalastat) AT1001-012 NCT01218659
C0013227 (UMLS CUI-2)
C0013227 (UMLS CUI [2])
C0013227 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])